Source-based medicine information

Maraviroc

Maraviroc: free medicine identity, available formulation details and reference links. Generic / active ingredient: maraviroc.

Free preview

Essential record information

Public access

Review the free medicine identity and available source information for Maraviroc. Detailed uses, safety and interaction information is in this page’s access section.

Maraviroc

Active ingredient / generic name: maraviroc
ATC code: J05AX09
Administration route: Oral

Record type: Medicine information record
Source record version: SPL v26; effective 2022-09-26; posted 2026-06-24; checked 2026-11-04

Record sources

Source checked: 2026-11-04

A source check is not an independent clinical review.

Access to this record

Free preview: Medicine identities, available source links and, where available, selected low-level related interaction records.
Paid details: Available detailed medicine uses, safety information and interaction context require access to this record.

A single-page purchase unlocks this resource only. Membership provides the page allowance shown in your plan; it does not unlock every related record automatically.

This page only: 6.00 USD One-time payment
Monthly membership: 40.00 USD / month · starting price

A verified account is required. Monthly membership renews automatically with no trial period. Taxes and the final total appear in checkout.

Examples selected from real records

Selected free interaction examples

Free

Selected low-level interaction records involving this medicine and other medicines are shown. This is not the complete interaction list.

Published related records: 28. The selection below does not represent the complete list.

Informational

Maraviroc + Tenofovir disoproxil fumarate

Recorded classification; this selection is not a full list or a conclusion that use is safe.

dailymed.nlm.nih.gov Source checked: 2026-11-04

View record

Informational

Maraviroc + Raltegravir

Recorded classification; this selection is not a full list or a conclusion that use is safe.

dailymed.nlm.nih.gov Source checked: 2026-11-04

View record

Informational

Lamivudine + Maraviroc

Recorded classification; this selection is not a full list or a conclusion that use is safe.

dailymed.nlm.nih.gov Source checked: 2026-11-04

View record

Important information and detailed context

Unlock medicine and interaction details

The basic information is available above. Details such as explanations of moderate or severe interaction records, mechanisms and clinical context are available through paid access to the relevant record or your membership allowance.

The related record group also includes interactions classified as moderate or severe. Each record’s access right applies to its own details.

Uses and medicine information
Safety and special circumstances
Side effects and interaction details

This page only

6.00 USDOne-time payment

Permanent access to the selected resource. No subscription required.

Buy access to this page

Monthly membership

40.00 USD/ month · starting price

A monthly page allowance for your plan. Revisit pages unlocked during the same billing period.

Explore memberships

Monthly memberships renew automatically; there is no trial period. Taxes and the final total appear in checkout.

A verified account is required. Turkish and English versions of the same resource share one access right.

Check medicine interactions

Results show the recorded information for the two medicines. A missing record does not mean there is no interaction.

Results open in English when available, otherwise in Turkish. Each record keeps its own access requirements.

This information is not personal treatment advice. Discuss treatment decisions with your doctor or pharmacist.